Suspension of trading

DiaSys Corporation Stock

Stocks

DYXC

US2528381070

Advanced Medical Equipment & Technology

OTC Markets Traded
Delayed OTC Markets 16:44:37 08/07/2025 +03 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44K 45K 41.5K 38.33K 72.74K 4.91M 73.96K 496K 195K 2.42M 193K 189K 8.31M P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 646K 565K 521K 481K 913K 61.6M 929K 6.23M 2.44M 30.34M 2.42M 2.37M 104M EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.23%+1.65%+22.15%+1.80% 195B
-1.68%-6.38%-22.97%+19.08% 146B
-1.20%-0.17%-57.13%-15.51% 66.87B
+0.04%-3.99%+15.96%-0.28% 52.59B
+0.61%-1.09%-27.71%-30.42% 43.85B
+0.17%+2.56%+7.87%+13.17% 37.73B
+0.12%-0.19%+7.05%+42.89% 37.03B
-1.56%-6.08%-20.51%-5.30% 30.07B
-0.04%-0.30%-15.50%-19.85% 29.43B
Average -0.26%-1.70%-10.09%+0.62% 63.83B
Weighted average by Cap. -0.41%-1.81%-5.86%+3.27%

Financials

2006 2007
Net sales 1.69M 1.48M 1.36M 1.26M 2.39M 161M 2.43M 16.27M 6.39M 79.31M 6.34M 6.2M 273M 1.68M 1.47M 1.35M 1.25M 2.37M 160M 2.41M 16.18M 6.35M 78.85M 6.3M 6.16M 271M
Net income -1.05M -917K -845K -781K -1.48M -99.93M -1.51M -10.1M -3.97M -49.23M -3.93M -3.85M -169M -785K -687K -634K -585K -1.11M -74.89M -1.13M -7.57M -2.97M -36.89M -2.95M -2.88M -127M
Net Debt 302K 264K 244K 225K 427K 28.8M 434K 2.91M 1.14M 14.19M 1.13M 1.11M 48.78M 594K 520K 480K 443K 840K 56.69M 855K 5.73M 2.25M 27.93M 2.23M 2.18M 96.01M
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock